Jun Hihara

Dr. Jun Hihara


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2018 in Translational Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
JHJun Hihara
Jun Hihara
HMHidenori Mukaida
Hidenori Mukaida
NHNaoki Hirabayashi
Naoki Hirabayashi
Gastrointestinal stromal tumors (GISTs) often arise in the stomach and small intestine, while esophageal GISTs are rare. Due to their rarity, clinicopathological data on esophageal GISTs are extremely limited, and this results in a lack of clear recommendations concerning optimal surgical management for esophageal GISTs. It is difficult to distinguish esophageal GIST from leiomyoma, the most frequent esophageal mesenchymal tumor, prior to resection, because the two types of tumors appear similar on computed tomography (CT), endoscopic ultrasound (EUS), and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Fine-needle aspiration biopsy (FNAB) under EUS enables definitive diagnosis, but it is often avoided because scarring could make enucleation more difficult and increase the risk of tumor dissemination by capsule destruction. Esophageal segmental and wedge resections are not usually performed due to the anatomical peculiarity of the esophagus, and the surgical options are limited to the highly invasive esophagectomy or the much less invasive surgical tumor enucleation. The decision as to which surgical procedure should be performed for esophageal GISTs is still under debate. Tumor enucleation may be permitted for smaller tumors, and esophagectomy may be recommended for larger GISTs or high-risk tumors with a high mitotic rate. The purpose of neoadjuvant imatinib administration is downsizing of the GIST to reduce the extent of resection and to reduce the risk of intraoperative complications, including tumor rupture. The efficacy of neoadjuvant/adjuvant imatinib therapy for esophageal GISTs is poorly understood, because the reports are limited to case reports or case series with small numbers. More clinicopathological data and clinical trials for esophageal GIST are expected.

20 December 2022 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
THTetsuhiro Hara
Tetsuhiro Hara
TATomohiro Adachi
Tomohiro Adachi
KSKensuke Shimbara
Kensuke Shimbara
YKYuichiro Kai
Yuichiro Kai
NHNaruhiko Honmyo
Naruhiko Honmyo
HMHidenori Mukaida
Hidenori Mukaida
Morgagni hernia is a rare form of diaphragmatic hernia. It is located at the anterior edge of the diaphragm and does not have an anterior rim. It is difficult to achieve a secure closure and maintain the tension of closure with laparoscopic surgery. We have performed laparoscopic resection of colorectal cancer and hernia repair simultaneously. An 89-year-old woman underwent laparoscopic hernia repair and ileocecal resection simultaneously. Regarding hernia repair, we considered that it would be difficult to use a mesh from the viewpoint of infection due to the colectomy. Therefore, we have done the extra-abdominal suture method. After laparoscopic ileocecal resection, a small incision was made in the epigastric region, and Morgagni hernia repair was performed with extra-abdominal sutures. She had no recurrence of either colon cancer or hernia for 22 months post-operatively. The extra-abdominal suture method can provide secure closure of the hernia orifice for Morgagni hernia.

4 June 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
SFShoichi Fumoto
Shoichi Fumoto
KTKeiji Tanimoto
Keiji Tanimoto
TNTakuya Noguchi
Takuya Noguchi
JHJun Hihara
Jun Hihara
EHEiso Hiyama
Eiso Hiyama
KHKeiko Hiyama
Keiko Hiyama
Background/Objective: The Empty Spiracles Homeobox 2 (EMX2) gene is a homeobox transcription factor that is critical for the development of the central nervous system and genitourinary system during embryogenesis. EMX2 has been shown to regulate cellular differentiation, migration, and proliferation through its involvement in transcriptional control. Dysregulation of EMX2 expression has been implicated in various pathological conditions, including cancer, but the precise molecular mechanisms underlying EMX2 functions in cancer remain incompletely understood. In this study, we focus on the expression profile and the prognostic significance of EMX2 in esophageal squamous cell carcinoma (ESCC). Methods/Results: The expression levels of EMX2 in clinical ESCC samples varied and appeared to be lower than those in adjacent normal tissues. In addition, EMX2 expression was detected in some of the 20 ESCC cell lines but not in others and was correlated with 5-FU sensitivity. EMX2 expression in ESCC cell lines was strongly associated with colony formation capacity in soft agar, and EMX2 knockdown decreased colony formation. Enforced expression of EMX2 decreased the side population (SP) ratio in FACS analysis but increased colony formation in SP fractions. Although it is a preliminary experiment, xenograft in immunodeficient (NOD) scid mice suggested that the forced expression of EMX2 increased tumorigenic capacity in vivo. A Kaplan–Meyer analysis of patients from whom 20 ESCC cell lines or 18 ESCC tissue samples were obtained indicated that EMX2 expression was a poor prognostic marker. Conclusion: EMX2 has a unique function in ESCC stemness and its expression is the stamped marker of poor prognosis in ESCC patients.

30 October 2026 in Discover Aging
Verified
Journal Article
Open access
PDF file
KKKosuke Kobayashi
Kosuke Kobayashi
SWShoji Wakabayashi
Shoji Wakabayashi
JUJun Ushirogochi
Jun Ushirogochi
KYKyoko Yamamoto
Kyoko Yamamoto
RTRyoji Taniguchi
Ryoji Taniguchi
JHJun Hihara
Jun Hihara
Purpose: We investigated whether basic movement ability was associated with whether a fall occurred inside or outside the patient room among older acute-care inpatients who had already experienced a fall. This study did not evaluate fall occurrence or fall risk in the overall inpatient population. Methods: This retrospective study included 688 fall events among inpatients aged 65 years or older who were already receiving physical therapy when the fall occurred (May 2022 to February 2026). Falls were classified as occurring inside or outside the patient room. Three logistic regression models were built: Model 1 (age, days to fall, work shift), Model 2 (Model 1 plus ABMS II score), and Model 3 (Model 2 plus cognitive function). Fit was evaluated by the area under the receiver operating characteristic curve (AUC). Results: Falls outside the room occurred in patients with higher ABMS II scores (median [IQR]: 27 [24–29] vs. 22 [18–26]). The AUC improved from 0.651 (Model 1) to 0.777 (Model 2) and 0.801 (Model 3). In Model 3, each additional ABMS II point was independently associated with higher odds of falls outside the room (OR: 1.20, 95% CI: 1.12–1.29, p < 0.001), while each one-category deterioration in pre-admission cognitive function was negatively associated (OR: 0.41, 95% CI: 0.25–0.67, p < 0.001). In an exploratory, hypothesis-generating analysis, an ABMS II cutoff of 26 points was associated with out-of-room falls after full adjustment (OR: 3.39, 95% CI: 2.01–5.72, p < 0.001). Conclusions: Among older acute-care inpatients who experienced a fall, preserved basic movement ability was associated with the fall occurring outside the patient room. Basic movement ability may therefore provide useful information for characterizing the spatial context of falls among fallers.